Patents by Inventor Jost Vielmetter

Jost Vielmetter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050244954
    Abstract: The invention relates to compositions and methods useful in the acceleration of binding of target analytes to capture ligands on surfaces. Detection proceeds through the use of an electron transfer moiety (ETM) that is associated with the target analyte, either directly or indirectly, to allow electronic detection of the ETM.
    Type: Application
    Filed: March 16, 2005
    Publication date: November 3, 2005
    Inventors: Gary Blackburn, Stephen Creager, Scott Fraser, Bruce Irvine, Thomas Meade, Stephen O'Connor, Robert Terbrueggen, Jost Vielmetter, Thomas Welch
  • Publication number: 20050142133
    Abstract: The present invention relates to optimized proteins that target the Epidermal Growth Factor Receptor (EGFR), and their application, particularly for therapeutic purposes.
    Type: Application
    Filed: December 3, 2004
    Publication date: June 30, 2005
    Inventors: Gregory Lazar, Wei Dang, John Desjarlais, Philip Hammond, Jost Vielmetter
  • Publication number: 20050003399
    Abstract: The invention relates to compositions and methods useful in the acceleration of binding of target analytes to capture ligands on surfaces. Detection proceeds through the use of an electron transfer moiety (ETM) that is associated with the target analyte, either directly or indirectly, to allow electronic detection of the ETM.
    Type: Application
    Filed: April 12, 2004
    Publication date: January 6, 2005
    Inventors: Gary Blackburn, Stephen Creager, Scott Fraser, Bruce Irvine, Thomas Meade, Stephen O'Connor, Robert Terbrueggen, Jost Vielmetter, Thomas Welch
  • Publication number: 20040121953
    Abstract: The present invention relates to variant thrombopoietin proteins that possess thrombopoiesis-stimulating activity and have reduced immunogenicity. In particular, variants of thrombopoietin with reduced ability to bind one or more human class II MHC molecules are described.
    Type: Application
    Filed: August 11, 2003
    Publication date: June 24, 2004
    Inventors: Arthur J. Chirino, Jamal El Yazal, Shannon Alicia Marshall, Peter McDonnell, Jost Vielmetter
  • Publication number: 20030130827
    Abstract: The invention relates to the use of protein design automation (PDA™) to generate computationally prescreened secondary libraries of proteins, and to methods and compositions utilizing the libraries.
    Type: Application
    Filed: August 12, 2002
    Publication date: July 10, 2003
    Inventors: Joerg Bentzien, Bassil I. Dahiyat, John R. Desjarlais, Robert J. Hayes, Jost Vielmetter